strh p/midstream bakken technic call today
featur justin kringstad director north dakota
bakken item discuss confer call
growth forecast oil ga
exist forecast pipelin
lead expert state regard north dakota
midstream environ justin address topic
along brief present follow live investor
welcom submit question ahead time ask
live call
avail decemb ct
hold unman progress continu valuat keep
us ground rais pt recent investor
meet manag indic
compani unman segment move closer take flight
unfortun valuat keep us ground hold
rate increas pt base updat
unman scenario model five unman system
contract believ opportun unman
tactic aircraft market move closer realiti new model
assum six platform drive substanti unit product
sharp revenu growth execut competit
fund watch item michael ciarmoli
semi compon distributor trump/xi
meet result construct white hous press statement
offer hope resolut trade disput believ
construct semi especi nxpi near-term
long-term situat isnt clear negoti
day establish detail non-tariff barrier like ip right
elud us busi two decad tariff
remain place agreement isnt reach day
tariff jump favorit idea remain structur grower
 biotech monthli monitor preview
good pressur stock buyer strike
electr power util power/util monthli regulatori
 show growth fuel northeast tx
ok also fresh high
stabil price posit best
game game takeaway lodg game
hotel octob
midstream oil ga midstream thought
semi compon distributor meet
commentari construct semi detail remain flux
et confer call north dakota pipelin
especi wash cyclic nxpi
rivo-cel improv surviv posit eu file
bellicum present data rivo-cel pediatr
patient malign non-malign diseas surviv data
non-malign patient remain encourag ef
prior compar
data cumul os patient trm
aml data remain encourag approxim line
prior rf vs prior
os vs prior reiter
 peter lawson
data support target promot erythroid defect
 edita gave oral
present compar two approach increas hemoglobin
level import variou hemoglobinopathi oral
present note target promot could
superior typic approach akin use
crispr sangamo nr encourag
edita system analysi heme approach import
data flow reiter may
drive weak crsp encourag potenti data
flow crsp beta-thal/sickl cell oncolog
path forward friday nk stori unfold attend
data remain encourag
combo hodgkin lymphoma highest dose cr rate
tick alon
orr remain patient show deepen
respons transplant elig encourag mono agent
activ cutan lymphoma post brentuximab
vedotin failur gain initi insight nk
cell/md collabor -- could becom key driver
path like highlight day friday data
reiter peter lawson
game recent host annual lodg game
leisur confer boston high-level commentari
game compani attend posit came
away increment posit meaning option
valu potenti sport bet partnership pnk synergi
target stabl overal region trend strong reit
pipelin favor game technolog environ
oper react higher qualiti slot content addit key
takeaway detail compani insight present
consum lodg leisur takeaway
lodg game leisur summit last week host
annual lodg game leisur confer boston
page
attend hotel c-corp hotel reit game
vacat ownership cruis compani major takeaway
corpor meet lodg vacat ownership
cruis line name present note pleas see
separ note game takeaway patrick schole
 explor product oil like rise/stabil
saudi/russia us/china canada decis like
remain key investor driver earn valuat eventu
matter investor ps wait make
execut hire rate highlight bullish omni-
channel/digit commerc stat industri updat relat
game recent host annual lodg game
leisur confer boston high-level commentari
game compani attend posit came
away increment posit meaning option
valu potenti sport bet partnership pnk synergi
target stabl overal region trend strong reit
pipelin favor game technolog environ
oper react higher qualiti slot content addit key
takeaway detail compani insight present
consum lodg leisur takeaway
lodg game leisur summit last week host
annual lodg game leisur confer boston
attend hotel c-corp hotel reit game
vacat ownership cruis compani major takeaway
corpor meet lodg vacat ownership
cruis line name present note pleas see
separ note game takeaway patrick schole
thought wolfskin deal reiter buy rate
follow today dim reaction wolfskin
acquisit acknowledg risk/reward profil may
par recent acquisit believ set
low bar n-t jw attract roic/margin stori
next year michael swartz
consum stapl last week zinc price decreas
lower zinc price could posit impact
compani univers william
electr power util
page
electr power util report focus regulatori
trend impact util coverag includ pend rate
case statu merger approv process new rate design
electr power util power/util macro trend
tracker declin forward spread report includ
analysi key macro factor impact power/util
sector includ forward price spark spread dark spread
nation weather pattern base latest peer group
valuat increas price target
 ali agha
 explor product oil like rise/stabil
saudi/russia us/china canada decis like
remain key investor driver earn valuat eventu
matter investor ps wait make
midstream oil ga tristan richardson
weekli sector comparison compani includ
wrd neal dingmann well
product bcf/d m/m versu last month bcf/d
trail twelv month averag bcf/d off-shore volum
bcf/d m/m drive bcf/d m/m
increas ga product septemb alreadi expect
see page know growth came primarili
northeast permian/eagl ford mid-con
grow slower last month move well fitzpatrick
estim pt reiter thesi buy rate
ainv follow compani one three revers stock split
becam effect close busi novemb
believ compani continu reposit portfolio
could acceler increment leverag provid
upsid current estim adjust nii/shar
estim nii/shar estim
goe reflect one-for-thre revers stock
split pt equat vs larg peer
page
rivo-cel improv surviv posit eu file
bellicum present data rivo-cel pediatr
patient malign non-malign diseas surviv data
non-malign patient remain encourag ef
prior compar
data cumul os patient trm
aml data remain encourag approxim line
prior rf vs prior
os vs prior reiter
 peter lawson
data support target promot erythroid defect
 edita gave oral
present compar two approach increas hemoglobin
level import variou hemoglobinopathi oral
present note target promot could
superior typic approach akin use
crispr sangamo nr encourag
edita system analysi heme approach import
data flow reiter may
drive weak crsp encourag potenti data
flow crsp beta-thal/sickl cell oncolog
path forward friday nk stori unfold attend
data remain encourag
combo hodgkin lymphoma highest dose cr rate
tick alon
orr remain patient show deepen
respons transplant elig encourag mono agent
activ cutan lymphoma post brentuximab
vedotin failur gain initi insight nk
cell/md collabor -- could becom key driver
path like highlight day friday data
reiter peter lawson
mid-dos durabl week
updat data on-going phase i/ii studi
hemophilia demonstr factor viii activ stabl
week low-dos week mid-dos
cohort data look good unlik move share
view spark expect provid updat
phase i/ii studi addit patient longer
follow-up data result product manufactur
suspens cultur compani on-track initi
phase run-in studi edward nash
safeti signal could overshadow encourag durabl
potenc data updat data give
page
us confid lentiglobin express sustain
month howev emerg sae like busulfan
relat myelodysplast syndrom excess blast may
lead investor re-think risk/benefit ratio lentiglobin
scd potenti -thalassemia addit data continu
demonstr could potent
persist r/r-mm believ share
could pressur given emerg safeti concern
lentiglobin well gener risk-sensit environ
updat fy sale estimate
report exh report vs
consensu rep in-lin w/compani guidanc
end report
ep estimate consensu
 in-lin w/ guidanc forecast
fy cc growth cvg mitg rtg
vs guidanc respect
valuat pt reiter buy bruce nudel
momentum continu updat revenue/lp
estim cc report exh vs
prior cc consensu
ww algovita sale
estim increas prior due grow
traction strong market growth model approv
 virti entri us sn market sometim
 model ex-u sn sale estim await
nvtr decis pursu clinic study/path toward ce
commentari encourag follow rmed result
updat revenue/lp estim
compar consensu report
vascular sale estim prior
dermatolog estim prior model
gross margin prior compar consensu
rel valuat base pt remain reiter
 nbi btk perform
month flat vs nbi
btk biotech trade
price-to-earnings low see exhibit data risk way next
week san antonio see upsid sector
exhibit potenti transform medicin approach
approv enter clinic despit neg sentiment
reiter posit outlook space buy
page
crsp cyad qure strh
laboratori corpor america hold lh
day takeaway analyst day focus sever area
capabl capit deploy reimburs head
wind acceler trend around organ volume/
big opportun on-going cost initi help
provid off-set continu like long-term fundament
view larg independ best posit maintain
hold cut pt ep tie
modestli lower multipl new estim david
preclin data sclc posit
ovarian phase data increment posit
new pre-clin data singl agent
combin small cell lung cancer add
confid around clinic develop program
ovarian prostat cancer initi repres
pt near term focus sierra plan
initi phase trial niraparib mcrpc
ovarian data on-going phase studi hgsoc
track plu see momelotinib data
weekend reiter buy peter lawson
hold unman progress continu valuat keep
us ground rais pt recent investor
meet manag indic
compani unman segment move closer take flight
unfortun valuat keep us ground hold
rate increas pt base updat
unman scenario model five unman system
contract believ opportun unman
tactic aircraft market move closer realiti new model
assum six platform drive substanti unit product
sharp revenu growth execut competit
fund watch item michael ciarmoli
auto china remain construct
note china growth stori pois inflect
expect new car compli new emiss
standard ngvt carbon solut captur share
produc local thu tariff exposur minim
us china play growth support
page
emerg region europ new ip target bp
chemic ebitda margin expans valuat
undemand view ebitda reiter
build products/dur good despit somewhat
ralli past sever week build product durabl
good index still year
mid septemb vs name
drop significantli declin lack buyer
short interest increas modest best
still histor low combin weaken data
fear rate increas result buyer strike
effect stock believ hous would need post
signific neg result drive spike short interest
stock pressur keith hugh
lodg reit octob modest bp gop margin
growth approx total revpar monthli analysi
oper level metric nearli thousand upper-
tier full servic hotel data sourc hotstat continu
forecast slightli posit margin see
margin closer flat slightli room revpar
rel respect octob howev gop margin
abl eek slight increment gain month
perform speak macro trend rise labor benefit
cost comparison noisi hurrican patrick
reit reit adjust estim updat
earn estim
base third quarter result earn confer
call commentari adjust revenu growth expens
assumpt rais pt
reduc pt
 ki bin
coverag drop coverag lasal hotel properti
lho result closur merger pebblebrook
hotel trust nr last rate stock hold
research issu date coverag
termin reli upon go forward patrick
semi compon distributor trump/xi
meet result construct white hous press statement
offer hope resolut trade disput believ
construct semi especi nxpi near-term
long-term situat isnt clear negoti
day establish detail non-tariff barrier like ip right
elud us busi two decad tariff
remain place agreement isnt reach day
page
tariff jump favorit idea remain structur grower
especi wash cyclic nxpi
execut hire rate highlight bullish omni-
channel/digit commerc stat industri updat relat
inc hold top question
analyst day hope walk away ad
stronger understand compani grow portfolio
busi importantli risk opportun
ahead rise rate pressur refi segment
management diversif strategi help mitig much
pressur operational/financi scale person
digit help gain disproportion share
differ segment view valuat deceler
organ growth keep us neutral youssef
internet on-line travel read
feel increment posit on-line travel follow
convers sever chain hotel particip
suntrust lodg game leisur summit
highlight includ sign far macro-rel slowdown
fwd-look travel indic commentari suggest
reduc risk ota disrupt googl hotel meta-search
 low likelihood major chang ota commiss
hotel loyalti push appear see good traction
like someth ota adapt think
remain favorit nave khan
page
dec t-mobil us inc dinner head ir director ir specialist ir senior analyst ir new york
dec inc ndr cfo vice-president treasuri ir new york
dec mgp ingredi inc ndr ceo cfo sr director ir boston new york
dec corp ndr ceo cfo/treasur boston new york
dec seacoast bank corp florida ndr ceo cfo west coast new
dec dinner head ir princip analyst ir boston
dec cst conf call north dakota pipelin author
dec patrick schole barri jona lodg leisur game mid-west
dec jennif demba michael young- bank west coast
dec youssef squali nave khan internet digit media texa
jan patrick schole barri jona lodg leisur west coast new
page
issu research report suntrust robinson humphrey inc analyst name report herebi certifi
recommend opinion express accur reflect research analyst person view
subject secur compani discuss herein part research analyst compens directli
indirectli relat specif recommend view express report
